TB CAB: Open letters to drug companies and FDA on delanamid and bedaquiline

By TB CAB
Published: May 25, 2012, 9:48 p.m.· Tags: None

Open letters to Otsuka, Janssen Pharmaceutical Companies of Johnson & Johnson, Food and Drug Administration and European Medicines Agency.

TB CAB: Open letter

By TB CAB
Published: April 16, 2012, 10:08 p.m.· Tags: None

Open letter regarding Cepheid pricing of the GeneXpert machines and cartridges for high-burden settings in the public and private sectors.

TB CAB: Open letter

By TB CAB
Published: April 12, 2012, 4:23 p.m.· Tags: None

Open letter to the Medicines Control Council and Ministry of Health on urgent need for compassionate use of bedaquiline for XDR-TB and pre-XDR-TB in South Africa.